328 related articles for article (PubMed ID: 29745917)
1. WHICH FACTORS MAY AFFECT THE QUALITY OF LIFE IN PATIENTS WITH TYPE 1 DIABETES MELLITUS USING THE MEDTRONIC VEO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION PUMP?
Thomakos P; Panagopoulos G; Kepaptsoglou O; Zoupas C; Mitrakou A
Georgian Med News; 2018 Apr; (277):61-67. PubMed ID: 29745917
[TBL] [Abstract][Full Text] [Related]
2. Fear of hypoglycemia in type 1 diabetes managed by continuous subcutaneous insulin infusion: is it associated with poor glycemic control?
Nixon R; Pickup JC
Diabetes Technol Ther; 2011 Feb; 13(2):93-8. PubMed ID: 21284474
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of the Continuous Subcutaneous Insulin Infusion-Related Quality-of-Life (CSII-QOL) Scale.
Sakane N; Murata T; Tone A; Kato K; Kimura M; Kawashima S; Sawaki H; Hirota Y; Okada A; Kuroda A; Matsuhisa M; Watanabe T; Suganuma A; Nirengi S; Toyoda M
Diabetes Technol Ther; 2020 Mar; 22(3):216-221. PubMed ID: 31638420
[No Abstract] [Full Text] [Related]
4. MDI versus CSII in Chinese adults with type 1 diabetes in a real-world situation: based on propensity score matching method.
Yu J; Wang H; Zhu M; Xu J
Health Qual Life Outcomes; 2024 Jun; 22(1):47. PubMed ID: 38872219
[TBL] [Abstract][Full Text] [Related]
5. Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 × 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS).
Little SA; Leelarathna L; Walkinshaw E; Tan HK; Chapple O; Lubina-Solomon A; Chadwick TJ; Barendse S; Stocken DD; Brennand C; Marshall SM; Wood R; Speight J; Kerr D; Flanagan D; Heller SR; Evans ML; Shaw JA
Diabetes Care; 2014 Aug; 37(8):2114-22. PubMed ID: 24854041
[TBL] [Abstract][Full Text] [Related]
6. Continuous Subcutaneous Insulin Infusion in Adult Type 1 Diabetes Mellitus Patients: Results from a Public Health System.
Moreno-Fernandez J; Gomez FJ; Pinés P; González J; López J; López LM; Blanco B; Roa C; Herranz S; Muñoz-Rodríguez JR
Diabetes Technol Ther; 2019 Aug; 21(8):440-447. PubMed ID: 31199682
[No Abstract] [Full Text] [Related]
7. Sustained efficacy of continuous subcutaneous insulin infusion in type 1 diabetes subjects with recurrent non-severe and severe hypoglycemia and hypoglycemia unawareness: a pilot study.
Giménez M; Lara M; Conget I
Diabetes Technol Ther; 2010 Jul; 12(7):517-21. PubMed ID: 20597825
[TBL] [Abstract][Full Text] [Related]
8. Comparison of treatment with continuous subcutaneous insulin infusion versus multiple daily insulin injections with bolus calculator in patients with type 1 diabetes.
Pérez-García L; Goñi-Iriarte MJ; García-Mouriz M
Endocrinol Nutr; 2015; 62(7):331-7. PubMed ID: 26234808
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
[TBL] [Abstract][Full Text] [Related]
10. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC
J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389
[TBL] [Abstract][Full Text] [Related]
11. Parental fear of hypoglycemia: young children treated with continuous subcutaneous insulin infusion.
Patton SR; Dolan LM; Henry R; Powers SW
Pediatr Diabetes; 2007 Dec; 8(6):362-8. PubMed ID: 18036061
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the effectiveness of long-term insulin pump therapy using a combined goal of HbA
Quirós C; Viñals C; Giménez M; Roca D; Conget I
Endocrinol Diabetes Nutr (Engl Ed); 2019 Nov; 66(9):534-539. PubMed ID: 31133475
[TBL] [Abstract][Full Text] [Related]
13. [Indications for the use of continuous subcutaneous insulin infusion in pediatric patients with type 1 diabetes mellitus].
Espejel-Huerta D; Antillón-Ferreira CA; Iglesias-Leboreiro J; Bernárdez-Zapata I; Martínez-Ramos Méndez A; Rendón-Macías ME
Rev Med Inst Mex Seguro Soc; 2016; 54(1):64-9. PubMed ID: 26820201
[TBL] [Abstract][Full Text] [Related]
14. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
Sulli N; Shashaj B
Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
[TBL] [Abstract][Full Text] [Related]
15. No association between fear of hypoglycemia and blood glucose variability in type 1 diabetes: The cross-sectional VARDIA study.
Saulnier PJ; Briet C; Gand E; Chaillous L; Dubois S; Bonnet F; Leguerrier AM; Fradet G; Delcourt Crespin I; Kerlan V; Gouet D; Perlemoine C; Ducluzeau PH; Pichelin M; Wargny M; Gonder-Frederick L; Ragot S; Hadjadj S; Cariou B;
J Diabetes Complications; 2019 Aug; 33(8):554-560. PubMed ID: 31182337
[TBL] [Abstract][Full Text] [Related]
16. Quality-of-life and treatment satisfaction in actual clinical practice of patients with Type 1 diabetes mellitus (T1DM) and hypoglycemia treated with insulin degludec.
Lecumberri E; Ortega M; Iturregui M; Quesada JA; Vázquez C; Orozco D
Curr Med Res Opin; 2018 Jun; 34(6):1053-1059. PubMed ID: 29300101
[TBL] [Abstract][Full Text] [Related]
17. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
[TBL] [Abstract][Full Text] [Related]
18. Influence of health locus of control and fear of hypoglycaemia on glycaemic control and treatment satisfaction in people with Type 1 diabetes on insulin pump therapy.
Indelicato L; Mariano V; Galasso S; Boscari F; Cipponeri E; Negri C; Frigo A; Avogaro A; Bonora E; Trombetta M; Bruttomesso D
Diabet Med; 2017 May; 34(5):691-697. PubMed ID: 28145047
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with glycemic control in adult type 1 diabetes patients treated with insulin pump therapy.
Matejko B; Skupien J; Mrozińska S; Grzanka M; Cyganek K; Kiec-Wilk B; Malecki MT; Klupa T
Endocrine; 2015 Feb; 48(1):164-9. PubMed ID: 24798448
[TBL] [Abstract][Full Text] [Related]
20. Clinical factors affecting the perception of hypoglycemia in type 1 diabetes patients treated with personal insulin pumps.
Matejko B; Grzanka M; Kieć-Wilk B; Małecki MT; Klupa T
Ann Agric Environ Med; 2013; 20(1):152-4. PubMed ID: 23540230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
